DEF 14A

Company

Entera Bio Ltd.

Filed

August 15, 2023

Period of Report

August 15, 2023

Accession Number

0001178913-23-002885

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →